Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Smith

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|June 16, 2006
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjectsTimothy E Graham, Qin Yang, Matthias Blüher, et al.
Plos One|July 23, 2013
A standardized vascular disease health check in europe: a cost-effectiveness analysisC Andy Schuetz, Peter Alperin, Swathi Guda, et al.
Nature Metabolism|August 22, 2022
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASHRitesh K Baboota, Aidin Rawshani, Laurianne Bonnet, et al.
Cell Metabolism|September 25, 2018
Methodological Issues in Studying PAHSA Biology: Masking PAHSA EffectsIsmail Syed, Jennifer Lee, Odile D Peroni, et al.
European Journal of Endocrinology|July 29, 2016
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trialDaniël H van Raalte, Mathijs C Bunck, Mark M Smits, et al.
European Journal of Endocrinology|January 15, 2014
The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetesDaniël H Van Raalte, Renate E van Genugten, Björn Eliasson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 12, 2021
Adipocyte precursor cells from first degree relatives of type 2 diabetic patients feature changes in hsa-mir-23a-5p, -193a-5p, and -193b-5p and insulin-like growth factor 2 expressionPaola Mirra, Antonella Desiderio, Rosa Spinelli, et al.
Clinical Epigenetics|September 7, 2023
Altered H3K4me3 profile at the TFAM promoter causes mitochondrial alterations in preadipocytes from first-degree relatives of type 2 diabeticsMichele Longo, Federica Zatterale, Rosa Spinelli, et al.
Scientific Reports|January 21, 2023
Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetesAraz Rawshani, Darren K McGuire, Elmir Omerovic, et al.
Plos Genetics|August 8, 2009
Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human geneticsHana Koutnikova, Markku Laakso, Lu Lu, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|June 16, 2006
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjectsTimothy E Graham, Qin Yang, Matthias Blüher, et al.
Plos One|July 23, 2013
A standardized vascular disease health check in europe: a cost-effectiveness analysisC Andy Schuetz, Peter Alperin, Swathi Guda, et al.
Nature Metabolism|August 22, 2022
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASHRitesh K Baboota, Aidin Rawshani, Laurianne Bonnet, et al.
Cell Metabolism|September 25, 2018
Methodological Issues in Studying PAHSA Biology: Masking PAHSA EffectsIsmail Syed, Jennifer Lee, Odile D Peroni, et al.
European Journal of Endocrinology|July 29, 2016
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trialDaniël H van Raalte, Mathijs C Bunck, Mark M Smits, et al.
European Journal of Endocrinology|January 15, 2014
The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetesDaniël H Van Raalte, Renate E van Genugten, Björn Eliasson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 12, 2021
Adipocyte precursor cells from first degree relatives of type 2 diabetic patients feature changes in hsa-mir-23a-5p, -193a-5p, and -193b-5p and insulin-like growth factor 2 expressionPaola Mirra, Antonella Desiderio, Rosa Spinelli, et al.
Clinical Epigenetics|September 7, 2023
Altered H3K4me3 profile at the TFAM promoter causes mitochondrial alterations in preadipocytes from first-degree relatives of type 2 diabeticsMichele Longo, Federica Zatterale, Rosa Spinelli, et al.
Scientific Reports|January 21, 2023
Cardiac arrhythmias and conduction abnormalities in patients with type 2 diabetesAraz Rawshani, Darren K McGuire, Elmir Omerovic, et al.
Plos Genetics|August 8, 2009
Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human geneticsHana Koutnikova, Markku Laakso, Lu Lu, et al.
Pageof 13